Cancer molecular diagnostics for early screening and diagnosis. Colofast: best in class blood...
Developing a cell expansion platform for automated mesenquimal and T-cell culture...
First-in-class, innovative therapeutics for the treatment of Rare and Ultra-Rare Diseases.
Exploring blockchain technology to improve efficiency, safety and patient value based healthcare.
Blood based biomarkers for early diagnosis of Alzheimer Disease. First product APOE4 test.
The company designs, manufactures and sells a proprietary portfolio of innovative...
Developing a proprietary technology with subfemtogram ultrasensibility for protein...
Metabolomic platform with first marketed non invasive diagnostic LDT for NASH.
dedicated PET & Molecular Imaging for Breast Cancer, Neurodegeneration and Surgery.
Market stage diagnostic drug for hypolactasia.
Pterostilbene formulations for derma and oncology
Health In Code
Market stage company focused on molecular genetic diagnosis of familial cardiac diseases.
Proprietary technology platform for the evelopment of biostimulants and biopesticides.
First in class small molecule for the targeted treatment of solid tumors.
Discovery and development of oligonucleotides as therapeutic agents.
Raman Health Technologies
New non invasive diagnostic technology platform based on Raman laser and Infrarred...